Facebook
Twitter
LinkedIn
ForwardStroke in the Cancer Patient
This course discusses stroke in the cancer patient, acute treatment for these patients and prevention techniques.
Target Audience
Adult and Pediatric Neurologists, Adult and Pediatric Oncologists, Neurosurgeons, Neuro-Oncologists, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Radiation Oncologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Respiratory Therapists and Clinical Pharmacists.
Learning Objectives
- Describe relevant data linking stroke and cancer.
- Select oncology patients with an acute ischemic stroke for reperfusion therapies.
- Recommend secondary prevention of stroke interventions in the cancer patient.
- Recognize the potential risks associated with drug interaction commonly used in cancer treatment.
Felipe De Los Rios La Rosa, M.D.
Medical Director, Comprehensive Stroke Center
Baptist Hospital
Miami, Florida
Felipe De Los Rios La Rosa, M.D., planning committee/symposium director for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Planning Committee/Symposium Directors
Kevin Abrams, M.D., indicated that he is a consultant to and is a stock shareholder in Keystone Heart.
Guilherme Dabus, M.D., indicated that he is a consultant to and is a member of the speakers' bureau for Medtronic, Microvention/Terumo and Penumbra; also, Dr. Dabus is a proctor for Medtronic, and is a consultant to Cerenovus; Dr. Dabus has also disclosed that he is a stock shareholder in Surpass/Stryker, Medtronic/Medina Medical, E-lum, InNeuroCo and Three Rivers.
Karel Fuentes, M.D., indicated that he is a consultant for Minnetronix.
Italo Linfante, M.D., indicated that he serves as a consultant to Covidien/Medtronic, Cerenovus, Stryker and Penumbra, and he is a member of the speakers' bureau for Medtronic/Coviden, Stryker and Cerenovus. Dr. Linfante is also a stock shareholder in InNeuroCo and Three Rivers, and a Proctor Pipeline and Barrel for Medtronic/Covidien for the United States and South America
Sergio Gonzalez-Arias, M.D., has no relevant financial relationships with ineligible companies* to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.
NOTE: Maintenance of Certification points are automatically reported. ABIM typically accepts or rejects submissions in approximately 48 hours. You will receive an email when your credits have been processed.
Available Credit
- 0.50 ABIM MOC II
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
- 0.50 Florida Board of Pharmacy
- 0.50 Florida Board of Respiratory Therapy
NOTE: Maintenance of Certification (MOC) points will be automatically reported to the ABIM. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
